THE ROLE OF SEVOFLURANE IN VETERINARY ANESTHESIA

Inhalant anesthetics are a daily tool in most veterinary practices, enabling safer procedures, diagnostic workups, and other interventions for a variety of species. Among popular inhalant agents, sevoflurane has emerged as a versatile and effective option. Favored for its rapid onset, smooth induction, and predictable recovery profile, many clinicians value sevoflurane for its fine control of anesthetic depth.

Despite its rising popularity, understanding sevoflurane’s pharmacology, physiologic effects, and practical considerations is key to safe, effective real-world use. This article provides an overview of sevoflurane’s role in veterinary anesthesia, including its pharmacology, practical applications, potential risks, and its comparison with the more familiar isoflurane.

Sevoflurane explained

Sevoflurane is a volatile, halogenated general anesthetic drug. Although less common in general practice than isoflurane, sevoflurane’s unique characteristics—including low solubility, reduced respiratory depression, and minimal airway irritation—make it advantageous in compromised, pediatric, anxious, and brachycephalic patients.

Sevoflurane is indicated for the induction and maintenance of general anesthesia in dogs. It is also used off-label in other species, including cats, small mammals, birds, and exotics. As an induction agent, sevoflurane may be administered via mask or induction chamber, along with oxygen, until the desired anesthetic depth is achieved. After endotracheal intubation, patients can be maintained on sevoflurane and oxygen for the duration of the procedure, if desired. Injectable premedication may also be used to achieve balanced anesthesia and analgesia.

Safe dosing and delivery of sevoflurane requires a precision vaporizer specifically calibrated for sevoflurane. This is because sevoflurane’s low solubility allows for more rapid changes in anesthetic depth. Without proper titration, monitoring, and patient support, accidental overdose can occur, or patients may wake up prematurely.

When used properly, sevoflurane has been demonstrated to be safe and effective for use in veterinary patients. Like the more familiar isoflurane, sevoflurane is largely eliminated through respiration, with only a small percentage being metabolized by the liver and excreted through the kidneys.

Pharmacology and physiology

After inhalation, sevoflurane diffuses through the lungs and into the bloodstream, where it travels to the brain to produce unconsciousness. Similar to other inhalant agents, sevoflurane can cause dose-dependent cardiovascular and ventilatory effects, including vasodilation and respiratory depression.

Sevoflurane has a relatively low minimum alveolar concentration (MAC) of 2.4% in dogs. This is slightly higher than isoflurane, which has a MAC of 1.3% in dogs. Because MAC is inversely related to potency, isoflurane is considered a more potent anesthetic agent.

Sevoflurane has a low blood-gas solubility, which is a key factor in its appeal in veterinary settings. Solubility refers to an agent’s absorption into the blood. In the case of sevoflurane, low solubility allows alveolar concentrations to rise and fall more quickly than highly soluble agents, aiding in rapid depth changes and finer depth control.

Unlike other inhalants, sevoflurane is uniquely non-pungent and only mildly irritating to airways, making it well-suited for mask and chamber inductions because it is less stressful for patients.

Advantages of sevoflurane

• Safe for induction: Sevoflurane is labeled for induction and maintenance of general anesthesia, making it effective for species or patients where mask or chamber induction is appropriate or preferred.
• Faster induction and recovery: Low solubility allows rapid increases and decreases in the amount of inhalant in the pet’s system.
• Rapid elimination, minimal metabolism: The majority of sevoflurane is eliminated by the lungs (~95–98%), and only a small fraction is metabolized by the liver and excreted by the kidneys.
• Finer depth control: Low solubility supports rapid titration and stable maintenance of general anesthesia.

Sevoflurane versus isoflurane

While isoflurane is generally considered the most common inhalant anesthetic used in veterinary medicine, sevoflurane is likely a close second. Despite similar safety profiles, key differences set them apart and result in distinct clinical advantages and limitations. These differences include:

• Cost and consumption: Sevoflurane is more expensive than isoflurane. In addition to higher per-unit cost and the need for a dedicated vaporizer, sevoflurane’s lower potency (higher MAC) requires higher vaporizer settings to maintain equivalent depths of anesthesia.
• Suitability for induction versus maintenance: Sevoflurane causes less respiratory irritation and is non-pungent, making it suitable for a safe, low-stress induction.
• Speed and precision of depth adjustment: Changes in anesthetic depth with isoflurane happen more slowly, requiring more deliberate titration. When rapid adjustment is needed, isoflurane’s slower response time can impact patient safety, comfort, or recovery.

Risks of sevoflurane in veterinary anesthesia

As with other inhalant agents, sevoflurane use is accompanied by potential risks and complications. These include:

• Dose-dependent respiratory depression or apnea
• Cardiovascular depression
• Bradycardia or hemodynamic instability
• Anesthetic overdose due to rapid depth changes (often caused by lack of training or familiarity)

Potential risks can be abated through proper staff education and training, including proper patient selection, ventilation, and continuous monitoring. Contraindications for sevoflurane use include patients with known sensitivity to other halogenated inhalants.

Safe use of sevoflurane in veterinary anesthesia

Best practices for safe and appropriate use of sevoflurane include:

• Patient selection and pre-anesthetic screening: This ensures appropriate and safe use of sevoflurane.
• Proper equipment: A dedicated sevoflurane vaporizer that is well-maintained and calibrated to deliver measured amounts of inhalant is necessary. Regular checks of all anesthetic equipment, including masks, circuits, tanks, endotracheal tubes, and scavenge equipment, ensure proper function and prevent leaks or failures.
• Team training: Every team member should be familiar with administering and monitoring sevoflurane, including its rapid effect on anesthetic depth, to reduce the risk of accidental overdose or premature patient arousal. Because sevoflurane is nonpungent, strict handling and safety measures should also be followed to minimize staff exposure. Exposure is hazardous to pregnant team members.
• Close monitoring: Continuous monitoring with electronic and manual methods ensures early identification of depth changes and informs anesthetist decisions.
• Multimodal anesthesia: Pre-anesthetic and perioperative sedation and/or analgesia can help reduce the amount of inhalant needed to attain the desired maintenance depth.

Better control with sevoflurane

Despite its higher price point, sevoflurane’s versatility, sensitivity, and safety make it a valuable inhalant for many veterinary professionals. When used with recognition of its unique properties and potential risks, along with diligent monitoring, sevoflurane can provide smooth and safe anesthesia for a variety of patients and procedures.

Education is the key to clinical confidence and patient safety. Build your team’s knowledge base while supporting better outcomes with our online Foundations of Anesthesia and Sedation certificate program. Interested in sourcing safe, trusted sedation and anesthesia products? Explore Parnell’s full line of products or contact our team.